Performance Evaluation of the Sysmex CS-5100 Automated Coagulation Analyzer

Coagulation testing is essential for diagnosing and monitoring bleeding disorders and anticoagulant therapy. Traditional methods require manual steps and can be time-consuming. Laboratories increasingly seek automated systems that offer faster results and higher throughput. Prior research has shown that automation improves efficiency and reduces human error. However, the performance of newer analyzers in real-world settings remains unclear. This gap motivated a detailed evaluation of the Sysmex CS-5100. No prior work had resolved how this device compares with existing models in terms of precision and sample handling. The need for reliable, high-throughput coagulation analyzers remains unmet in many clinical settings.

This study aimed to assess the performance of the Sysmex CS-5100 coagulation analyzer in a clinical setting. The focus was on evaluating its accuracy, precision, and suitability for high-volume testing. The researchers sought to compare it with the established Sysmex CA-7000 model. They examined key coagulation parameters like PT, INR, APTT, fibrinogen, and D-dimer. The goal was to determine if the CS-5100 could handle a wide range of sample types effectively. They also tested its performance with abnormal samples and icteric or lipemic specimens. The study aimed to confirm whether the device could meet clinical laboratory demands for speed and reliability. The findings would help guide adoption decisions in high-throughput environments.

The study compared the Sysmex CS-5100 with the Sysmex CA-7000 using a range of coagulation tests. They measured within-run and between-run coefficients of variation for PT, INR, APTT, and D-dimer. The researchers analyzed both normal and pathologic sample ranges to assess imprecision. They also evaluated throughput and the STAT function for urgent samples. Correlation coefficients were calculated between the two analyzers to assess agreement. The study tested for interference from bilirubin and triglycerides in the CS-5100. They used clinical samples to simulate real-world conditions. The methods included statistical analysis of precision and comparison metrics.

The within-run and between-run CVs for PT, INR, APTT, and D-dimer were within acceptable limits. The CS-5100 showed excellent performance in both normal and pathologic ranges. Correlation coefficients between the CS-5100 and CA-7000 were highly significant. The CS-5100 had a higher throughput rate than the CA-7000 model. No interference was observed from bilirubin or triglycerides in the CS-5100. The device handled icteric and lipemic samples without issues. The STAT function performed efficiently for urgent cases. These results suggest the CS-5100 is suitable for high-volume clinical use.

The authors concluded that the Sysmex CS-5100 offers satisfactory imprecision for coagulation testing. It performed well in both normal and abnormal sample ranges. The device’s throughput and STAT function meet clinical demands for speed. The absence of interference from bilirubin and triglycerides is a key advantage. The CS-5100 is well-suited for laboratories handling large volumes of samples. It is also suitable for icteric and lipemic specimens without performance loss. The correlation with the CA-7000 supports its reliability in routine testing. These findings suggest the CS-5100 is a viable option for clinical coagulation analysis.